Local thermal ablative therapies for extracranial oligometastatic disease of non-small-cell lung cancer

被引:2
|
作者
Kong, Yongmei [1 ,2 ,3 ]
Xu, Hui [1 ,2 ,3 ]
Huang, Yahan [1 ,2 ,3 ]
Wei, Zhigang [1 ,2 ]
Ye, Xin [1 ,2 ]
机构
[1] Shandong First Med Univ, Affiliated Hosp 1, Dept Oncol, Jinan 250000, Shandong, Peoples R China
[2] Shandong Prov Qianfoshan Hosp, Shandong Lung Canc Inst, Shandong Key Lab Rheumat Dis & Translat Med, Jinan 250000, Shandong, Peoples R China
[3] Shandong First Med Univ, Jinan, Peoples R China
基金
中国国家自然科学基金;
关键词
extracranial; non-small cell lung cancer; oligometastatic diseases; thermal ablation; RADIOFREQUENCY ABLATION; MICROWAVE ABLATION; CLASSIFICATION; RADIOTHERAPY; METASTASIS; OUTCOMES; TUMOR; CHEMOTHERAPY; METAANALYSIS; MULTICENTER;
D O I
10.1111/ajco.13766
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. Clinically, 40-50% of patients with NSCLC are found to have systemic metastasis at the initial diagnosis. Meanwhile, 30-75% of patients with lung cancer who have undergone radical surgical resection have local recurrence and distant metastases. However, not all distant metastases are multiple, and some are potentially curable. In this study, among the patients with NSCLC having distant organ metastasis, approximately 7% showed extrapulmonary solitary metastasis and remained in this relatively stable state for a long time. This form of metastasis is known as NSCLC oligometastases. This review describes the concept and classification of oligometastases, as well as the local treatment and prognosis of extracranial oligometastases.
引用
收藏
页码:3 / 8
页数:6
相关论文
共 50 条
  • [31] Personalized choice of maintenance therapies in non-small-cell lung cancer
    Blais, N.
    Corrales-Rodriguez, L.
    CURRENT ONCOLOGY, 2012, 19 : S64 - S72
  • [32] Patient Selection for Local Aggressive Treatment in Oligometastatic Non-Small Cell Lung Cancer
    Werner, Raphael S.
    Opitz, Isabelle
    CANCERS, 2021, 13 (24)
  • [33] Robot-assisted Extracranial Stereotactic Radiotherapy of Adrenal Metastases in Oligometastatic Non-small Cell Lung Cancer
    Celik, Eren
    Semrau, Robert
    Baues, Christian
    Trommer-Nestler, Maike
    Baus, Wolfgang
    Marnitz, Simone
    ANTICANCER RESEARCH, 2017, 37 (09) : 5285 - 5291
  • [34] Ablative therapy in oligometastatic non-small cell lung cancer-an editorial on recent evidence
    Niglas, Mark
    Cheung, Patrick
    JOURNAL OF THORACIC DISEASE, 2018, 10 (01) : 138 - 140
  • [35] IS THERE A ROLE FOR CHEMOTHERAPY OF NON-SMALL-CELL LUNG-CANCER
    HANSEN, HH
    ANNALS OF ONCOLOGY, 1995, 6 : 79 - 82
  • [36] Emerging antiangiogenic therapies for non-small-cell lung cancer
    Blakely, Collin
    Jahan, Thierry
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (10) : 1607 - 1618
  • [37] Targeted therapies and immunotherapy in non-small-cell lung cancer
    Cortinovis, D.
    Abbate, M.
    Bidoli, P.
    Capici, S.
    Canova, S.
    ECANCERMEDICALSCIENCE, 2016, 10
  • [38] Local Ablative Therapy Combined With Pembrolizumab in Patients With Synchronous Oligometastatic Non-Small Cell Lung Cancer A Recursive Partitioning Analysis
    Lee, Hye In
    Choi, Eun Kyung
    Kim, Su Ssan
    Shin, Young Seob
    Park, Junhee
    Choi, Chang-Min
    Yoon, Shinkyo
    Kim, Hyeong Ryul
    Cho, Young Hyun
    Song, Si Yeol
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (03): : 698 - 707
  • [39] Management of Oligometastatic Disease in Advanced Non-Small Cell Lung Cancer
    West, Howard
    CLINICS IN CHEST MEDICINE, 2020, 41 (02) : 249 - +
  • [40] Targeted Therapies for EGFR Exon 20 Insertion Mutation in Non-Small-Cell Lung Cancer
    Seo, Donghyun
    Lim, Jun Hyeok
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)